Advertisement
Biological Psychiatry
Advanced searchSave search
Research Article| Volume 34, ISSUE 4, P234-239, August 15, 1993

Download started.

Ok

The TRH-stimulation test in DSM-III personality disorder

DOI:https://doi.org/10.1016/0006-3223(93)90077-Q
The TRH-stimulation test in DSM-III personality disorder
Previous ArticleSerum and saliva cortisol relations in adolescents during pregnancy and the early postpartum period
Next ArticleImprovement in symptoms of depression and in an index of life stressors accompany treatment of severe hypertriglyceridemia
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The authors examined thyrotropin-releasing hormone (TRH) stimulation testing in the neuroendocrine evaluation of DSM-III major depressive disorder in 26 consecutive medication-free, medically healthy patients meeting a primary DSM-III diagnosis of axis II personality disorder. Thyroid-stimulating hormone (TSH) responses to TRH challenge were not significantly different between patients with or without major depression at time of study, or between patients with or without a life history of major affective disorder. Further, TSH responses to TRH among 11 healthy male nonpsychiatric controls were not significantly different from those in patients with personality disorders. Comparison of those patients with blunted TSH responses (<7.0 μU/ml) versus those without blunted response (≤7.0 μU/ml) also did not reveal a significant difference. In addition, the TSH response to TRH did not correlate with dimensional assessments of state or trait depression, anxiety, or with past history of suicide attempt or alcohol abuse. These data suggest that TRH stimulation testing has limited utility in the evaluation of major depression or other relevant affective states/traits in personality-disordered patients. Affective symptoms in personality-disordered patients do not seem to be associated with dysregulation of the hypothalamic-pituitary-thyroid axis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Coccaro E.F.
        • Siever L.J.
        • Klar H.M.
        • et al.
        Serotonergic studies in affective and personality disorder: correlates with suicidal and impulsive aggressive behavior.
        Arch Gen Psychiatry. 1989; 46: 587-599
        • Coccaro E.F.
        • Lawrence T.
        • Trestman R.
        • Gabriel S.
        • Klar H.M.
        • Siever L.J.
        Growth hormone responses to intravenous clonidine challenge correlates with behavioral irritability in psyciatric patients and in healthy volunteers.
        Psychiatry Res. 1991; 39: 129-139
        • Endicott J.
        • Spitzer R.
        A diagnostic interview: the schedule for affective disorders and schizophrenia.
        Arch Gen Psychiatry. 1978; 35: 837-844
        • Garbutt J.C.
        • Loosen P.T.
        • Tipermas A.
        • Prange A.J.
        The TRH test in patients with borderline personality disorder.
        Psychiatry Res. 1983; 9: 107-113
        • Garbutt J.C.
        • Loosen P.T.
        • Glenn M.
        Lack of effect of DA receptor blockade on the TSH response to TRH in borderline personality disorder.
        Psychiatry Res. 1987; 21: 307-311
        • Gunderson J.G.
        • Phillips K.A.
        A current view of the interface between borderline personality disorder and depression.
        Am J Psychiatry. 1991; 148: 967-975
        • Gunderson J.G.
        • Kolb J.E.
        • Austin V.
        The Diagnostic Interview for Borderline Patients.
        Am J Psychiatry. 1981; 138: 896-903
        • Kavoussi R.J.
        • siever L.J.
        Biologic validators of personality disorders.
        in: Oldham J. Personality Disorders: New Perspectives on Diagnostic Validity. American Psychiatric Press, Washington DC1991: 71-88
        • Livesley W.J.
        • Schroeder M.L.
        Dimensions of personality disorder: the DSM-III-R cluster A diagnoses.
        J Nerv Ment Dis. 1990; 178: 627-635
        • Loosen P.T.
        • Prange A.J.
        Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review.
        Am-J Psychiatry. 1982; 139: 405-416
        • Loosen P.T.
        • Garbutt J.C.
        • Prange A.J.
        Evaluation of the diagnostic utility of the TRH-induced TSH response in psychiatric disorders.
        Pharmacopsychiatry. 1987; 20: 90-95
        • Maes M.
        • Maes L.
        • Suy E.
        Symptom profiles of biological markers in depression: a multivariate study.
        Psychoneuroendocrinology. 1990; 15: 29-37
        • Mellsop G.
        • Varghese F.
        • Joshua S.
        • Hicks A.
        The reliability of axis II of DSM-III.
        Am J Psychiatry. 1982; 139: 1360-1361
        • Nathan S.R.
        • Soloff P.H.
        • George A.
        • Peters J.
        • McCarthy T.
        DST and TRH tests in borderline personality disorders.
        in: Shagass C. Biological Psychiatry-1985. Elsevier Science Publishing, New York1986: 566-568
        • O'Hanlon M.
        • Barry S.
        • Clare A.W.
        • Dinan T.G.
        Serum thyrotropin responses to thyrotropin-releasing hormone in alcohol-dependent patients with and without depression.
        J Affective Disord. 1991; 21: 109-115
        • Siever L.J.
        • Klar H.M.
        • Coccaro E.F.
        Psychobiologic substrates of personality.
        in: Klar H. Siever L.J. Biologic Response Styles: Clinical Implications. American Psychiatric Press, Washington DC1985: 38-66
        • Siever L.J.
        • Amin F.
        • Coccaro E.F.
        • et al.
        Plasma homovanillic acid in schizotypal personality disorder.
        Am J Psychiatry. 1991; 148: 1246-1248
        • Stangl D.
        • Pfohl B.
        • Zimmerman M.
        A structured interview for the DSM-III personality disorders.
        Arch Gen Psychiatry. 1985; 42: 591-596
        • Sternbach H.A.
        • Fleming J.
        • Extein I.
        • Pottash A.L.C.
        • Gold M.
        The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
        Psychoneuroendocrinology. 1983; 8: 459-462
        • Widiger T.A.
        • Trull T.J.
        • Hurt S.W.
        • Clarkin J.
        • Frances A.
        A multidimensional scaling of the DSM-III personality disorders.
        Arch Gen Psychiatry. 1987; 44: 557-563
        • Zanarini M.C.
        • Gunderson J.G.
        • Frankenburg F.R.
        Axis I phenomenology of borderline personality disorder.
        Compr Psychiatry. 1989; 30: 149-156
        • Zimmerman M.
        • Coryell W.H.
        DSM-III personality disorder dimensions.
        J Nerv Ment Dis. 1990; 178: 686-692

      Article info

      Publication history

      Received in revised form: May 12, 1993
      Received: November 11, 1992

      Identification

      DOI: https://doi.org/10.1016/0006-3223(93)90077-Q

      Copyright

      © 1993 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX